Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Snoussi, Kaouther ^a   Strosberg, A Donny ^b   Bouaouina, Noureddine ^a,c   Ahmed, Slim Ben ^c   Helal, Ahmed Noureddine ^d   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Scripps ^*  (United States)

^c FARHAT HACHED HOSPITAL   (Tunisia)

^d UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; RESTRICTION ENDONUCLEASE; CELL SURFACE RECEPTOR; LEPTIN RECEPTOR, HUMAN;

ALLELE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN POLYMORPHISM; RESTRICTION MAPPING; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TUNISIA; UNIVARIATE ANALYSIS; ADULT; AGED; BREAST TUMOR; CARCINOMA; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEPTIN; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, CELL SURFACE; RECEPTORS, LEPTIN; RISK ASSESSMENT; TUNISIA;

EID: 33644883030     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-38     Document Type: Article

References (79)

1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7-33.
2. Ries LAG, Kosary CI, Hankey BF, eds: SEER Cancer Statistics Review, 1973-1996. Bethesda, MD: National Cancer Institute; 1999.
3. Collaborative Group on Hormonal Factors in Breast Cancer: Breast Cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. Lancet 1997, 350:1047-1059.
4. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and Hormonal contraceptives: collaborative reanalysis of individual data on 53, 297 women with breast cancer and 100, 239 women without breast cancer from 54 epidemiological studies. Lancet 1996, 347:1713-1727.
5. Hulka BS, Stark AT: Breast cancer: cause and prevention. Lancet 1995, 346:883-887.
6. Kelsey JL: Breast cancer epidemiology: summary and future directions. Epidemio Rev 1993, 15:256-263.
7. World Cancer research Fund-American Institute of Cancer Research: Food, nutrition and the prevention of cancer: A global perspective. Mebesha USA: Banta Book Group 1997, S.252:.
8. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 2001, 89:51-62.
9. Clearly MP, Maihle NJ: The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 1997, 216:28-43.
10. Willett WC: Fat, energy and breast cancer. J Nutr 1997, 127:921S-3S.
11. Galanis DJ, Kolonel LN, Lee J, Le Marchand L: Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes Control 1998, 9:217-224.
12. Klurfeld DM, Lioyd LM, Welch CB, Davis MJ, Tulp OL, Kritchevsky D: Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rat by energy restriction. Proc Soc Exp Biol Med 1992, 196:381-384.
13. Waxler SH: Obesity and cancer susceptibility in mice. Am J Clin Nutr 1960, 8:760-766.
14. Heston WE, Vlahakis G: Genetic obesity and neoplasia. J Natl Cancer Inst 1962, 29:197-209.
15. Wolff GL, Kodell RL, Cameron AM, Medina D: Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c x VY) F1 hybrid mice. J Toxicol Environ Health 1982, 10:131-142.
16. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372(6505):425-432.
17. Campfield LA, Smith FJ, Guiez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549.
18. Hallaas J, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman J: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
19. Benett BD, Solar GP, Yuan JQ, Mathias J, Thomas JR, Matthews W: A role for leptin and its cognate receptor in hematopoiesis. Cur Biol 1996, 6:1170-1180.
20. Hoggard N, Hunter L, Trayhurn P, Williams LM, Mercer JG: Leptin and reproduction. Proc Nutr Soc 1998, 57:421-427.
21. Bouloumie A, Drexler HC, Lafontan M, Busse R: Leptin the product of Ob gene, promotes angiogenesis. Cir Res 1998, 269:546-549.
22. Loffreda S, yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM: Leptin regulates proinflammatory immune responses. FASEB J 1998, 12:57-65.
23. Green ED, Maffei M, Braden VV, Proenca R, DeSilva U, Zhang Y, Chua SC Jr, Leibel RL, Weissenbach J, Friedman JM: The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7. Genome Res 1995, 5:5-12.
24. Isse N, Ogawa Y, Tamura N, Masuzaki H, Mori K, Okazaki T, Satoh N, Shigemoto M, Yoshimasa Y, Nishi S, Hosoda K, Inazawa J, Nakao K: Structural organization and chromosomal assignment of the human obese gene. J Biol Chem 1995, 270:27728-27733.
25. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Human obese gene expression: Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995, 44:855-858.
26. Malik KF, Young WS 3rd: Localisation of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology 1996, 137:1497-1500.
27. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Murcer JG: Leptin and leptin recptor mRNA and protein expression in the murine foetus and placenta. Proc Natl Acad Sci USA 1997, 94:11073-11078.
28. Emilsson V, Liu YL, Awthorne MA, Morton NM, Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islet and direct inhibitory action of leptin on insulin secretion. Diabetes 1997, 46:313-316.
29. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, Snodgrass HR: Novel B219/OB receptor isoforms: possible role of leptin hematopoiesis and reproduction. Nat Med 1996, 2:585-589.
30. Briscoe CP, Hanif S, Arch JR, Tadayyon M: Leptin receptor long-form signalling in a human liver cell line. Cytokine 2001, 14:225-229.
31. Tsuchiya T, Shimiu H, Hori T, Mori M: Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 1999, 365:273-279.
32. Mix H, Widjaja A, Jandl O, Cornberg M, Kaul A, Goke M, Beil W, Kuske M, Brabant G, Manns MP, Wagner S: Expression of leptin receptor isoforms in the human stomach. Gut 2000, 36:457-461.
33. Tartaglia LA: The leptin receptor. J Biol Chem 1997, 272:6093-6096.
34. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K: No adipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997, 3:1029-1033.
35. Oliveira AM, Nashimento AG, Lloyd RV: Leptin and leptin receptor mRNA are widely expressed in tumors of adipocytic differenciation. Mod Pathol 2001, 14(6):549-555.
36. Morash B, Johnstone J, Leopold C, Li A, Murphy P, Ur E, Wilkinson M: The regulation of leptin gene expressioin in the C6 glioblastoma cell line. Mol Cell Endocrinol 2000, 165:97-105.
37. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, Muellner C, Speiser W, Wagner O: Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 1998, 83:1059-1066.
38. Umemoto Y, Tsuji K, Yang F-C, Ebihara Y, Kaneko A, Furukawa S, Nakahata T: Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood 1997, 90:3438-3443.
39. Dieudonne M-N, Machinal-quelin F, Serazin-Leroy V, Leneveu M-C, Pecquery R, Giudicelli Y: Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2002, 293:622-628.
40. Laud K, Gourdou I, Pessemess L, Peyrat JP, Djiane J: Identification of leptin receptors in human breast cancer: Functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002, 188:219-226.
41. Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M, Cooper D, Yasuda K: Leptin and high glucose stimulate proliferation in MCF-7 human breast cancer cells: Reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 2002, 1592(2):107-116.
42. Hu X, Juneja SC, Maihle NJ, Cleary MP: Leptin a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002, 94(22):1704-1711.
43. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C: Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho- and rac-dependent signalling pathways. FASEB J 2000, 14:2329-2338.
44. Hardwick JCH, Van Den Brink GR, Offerhaus GJ, Van Deventer SIH, Peppelenbosh MP: Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001, 121:79-90.
45. Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, Sato N: Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatol 2001, 34:288-297.
46. Islam MS, Morton NM, Hansson A, Emilsson V: Rat insulinoma-derived pancreatic β-cells express a functional leptin receptor that mediates a proliferative response. Biochem Biophys Res Commun 1997, 238:851-855.
47. Ishikawa M, Kitayama J, Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004, 10(13):4325-4331.
48. Caldefie-Chézet F, Damez M, de Latour M, Konska G, Mishellani F, Fusillier C, Guerry M, Penault-Llorca F, Guillot J, Vasson M-P: Leptin: A proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commu 2005, 334:737-741.
49. Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D: Leptin and insulin growth factor 1 in relation to breast cancer (Greece). Cancer Causes Control 2000, 11(5):383-388.
50. Coskun U, Gunel N, Toruner FB, Sancak B, Onuk E, Bayram O, Yilmaz E, Elbeg S, Ozkan S: Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma 2003, 50(1):41-46.
51. Tessitore L, Visio B, Pesola D, Cecchini f, Mussa A, Argiles JM, Benedetto C: Adipocytes expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Cancer 2004, 24(6):1529-1535.
52. Han C, Zhang HT, Du L, Liu X, Jing J, Zhao X, Tian B: Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 2005, 26(1):19-24.
53. Mammës O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, Colas-Linhart N, Fumeron F: Novel polymorphisms in the 5′ region of the LEP gene: Association with leptin levels and response to low-calorie diet in human obesity. Diabetes 1998, 47:487-489.
54. Gotoda T, Manning BS, Goldstone AP, Imrie H, Evans AL, Strosberg AD, McKeigue PM, Scott J, Aitman TJ: Leptin receptor gene variation and obesity; lack of association in a white British male population. Hum Mol Genet 1997, 6:869-876.
55. Le Stunff C, Le Bihan C, Schrk NJ, Bougneres P: A common Promoter Variant of the Leptin Gene Is Associated With changes in the Relationship Between Serum Leptin and Fat Mass in Obese Girls. Diabetes 2000, 49:2196-2200.
56. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P: A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002, 34:355-359.
57. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantrozos CS: The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 2001, 86:4434-4439.
58. Ben Ahmed S, Aloulou S, Bibi M, Landolsi A, Nouira M, Ben Fatma L, Kallel L, Gharbi O, khairi H, Kraiem C: Breast cancer detection in Tunisian women: an analysis of a hospital trial involving 729 patients. Santé Publique 2002, 14(3):231-241.
59. Oletup H, Zetterquiest H: HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in two hours: an alternative to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235.
60. Kaplan EL, Meir PO: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
61. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 1977, 35:1-39.
62. Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D'Agostino RB, Splansky GL, Anderson KM, Helsel WE: Body fat distribution and breast cancer in the Framingham study. J Natl Cancer Inst 1990, 82:286-290.
63. Takahashi Y, Okimura Y, Mizuno I, Iida K, Takahashi T, Kaji H, Abe H, Chihara K: Leptin induces mitogen-activated proteinkinase-dependent proliferation of C3H10T1/2 cells. J Biol Chem 1997, 272:12897-12900.
64. Na Y, Dan W, Hua Z, Xia Y, Xiaojing S, Huijian W, Ge W, Xinjuan W, Younfeng S: Molecular Mechanisms Involved in the Growth Stimulation of Breast Cancer Cells by Leptin. Cancer Res 2004, 64:5870-5875.
65. Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, Ando S: Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line. J Biol Chem 2003, 278:28668-28678.
66. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lobo F, Lopes C, Medeiros R: Overexpressing Leptin Genetic Polymorphism (-2548 G/A) Is Associated With Susceptibility to Prostate cancer and Risk of Advanced Disease. Prostate 2004, 59(3):268-274.
67. Kote-Jerai Z, Singh R, Durocher F, Easton D, Edwards SM, Ardern-Jones A, Dearnaley DP, Houlston R, Kirby R, Eeles R: Association between leptin receptor gene polymorphisms and early-onset prostate cancer. BJU Int 2003, 92(1):109-112.
68. Quinton ND, Alisson JL, Ross RJM, Eastell R, Blakemore AIF: A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian woman. Human Genet 2001, 108:233-236.
69. Woo HY, Park H, Ki CS, Park YL, Bae WG: Rlationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett 2005, 9:1-6.
70. Mantzoros CS, Bolhke K, Moschos S, Cramer CS: Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer 1999, 80:523-526.
71. Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N: Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 2005, 23:6037-6042.
72. Konopleva M, Mikhail A, Estrov Z, Zhao S, Harris D, Sanchez-Williams G, Kornblau SM, Dong J, Kliche KO, Jiang S, Snodgrass HR, Estey EH, Andreef M: Expression and function of leptin receptor isoforms in myeloid leukaemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood 1999, 93:1668-1676.
73. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schner JS, Scheabb MB, Polverini PJ, Flores-Riveros JR: Biological action of leptin as an angiogenic factor. Science 1998, 281:1583-1586.
74. Ribatti D, Nico B, Belloni AS, Vacca A, Roncali L, Nussdorfer GG: Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int J Mol Med 2001, 8:265-268.
75. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, Cho SY, Kim HS: Potential role of leptin in angiogenesis: Leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001, 33:95-99.
76. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997, 100:2777-2782.
77. Zumbach MS, Boehme MWJ, Wahl P, Stremmel W, Ziegler R, Nawroth PP: Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997, 82:4080-4082.
78. Janik JE, Curti BD, Considine RV, Rager HC, Powers GC, Alvord WG, Smith JW II, Gause BI, Kopp WC: Interleukin I α increases serum leptin concentrations in humans. J Clin Endocrinol Metab 1997, 82:3084-3086.
79. Reichlin S, Chen G, Nicolson M: Blood to brain transfer of leptin in normal and interleukin-1 β treated male rats. Endocrinol 2000, 141:1951-1954.